Free tool
Oncology stocks
We cover 2 companies grouped under the Oncology theme. The median market value in the group is $322.39B. Across the group, the median move over the past trading day is −1.32%. Price change over the past year runs from +10.2% to +75.8% across the middle 80 percent of the group, with a median of +43.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $380.73B | Mega cap | +83.96% | Oct 29, 2026 |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +1.98% | Oct 30, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.